Table 3. Summary of all variants in LCL, B95.8, and Jijoye samples compared to EBV-1 and EBV-2.

Variants vs. EBV-1
Sample	Total	Insertion	Deletion	Substitution	Intergenic	Genic Noncoding	Coding Synonymous	Coding Non-Synonymous
LCL1	968	19	20	929	511	232	136	87
LCL3	606	14	10	582	327	167	59	52
LCL9	969	22	22	925	496	242	137	92
LCL10	980	14	20	946	576	227	110	65
Common LCLs	178	2	0	176	77	56	24	20
B95.8	73	5	5	63	39	8	10	16
Jijoye	1234	13	24	1197	710	215	176	108
Common LCLs+ B95.8+Jijoye	5	0	0	5	4	0	0	1
Variants vs. EBV-2
LCL1	645	9	9	627	115	226	167	137
LCL3	597	8	11	578	96	226	150	125
LCL9	639	10	9	620	113	238	158	130
LCL10	316	5	9	301	57	117	88	53
B95.8	530	6	10	514	79	206	121	115
Jijoye	423	3	5	415	90	129	123	81
Common LCLs 1,3,9	418	5	7	406	65	166	91	96
Common LCL10+ Jijoye	176	1	2	173	20	50	69	37
Common LCLs 1,3,9+ B95.8	317	3	4	310	43	139	66	69
Common ALL LCLs	85	0	2	83	15	18	28	24
Common ALL samples	49	0	0	49	7	15	16	11

Summary of the mutations identified in the LCLs and control samples when compared to EBV-1, we noted that substitution was the most common type mutation, with Jijoye having the most and B95.8 having the least. Deletions and insertions were also observed ranging from 5 (B95.8) to 24 (Jijoye) and 5 (B95.8) and 13 (Jijoye) respectively. When compared to EBV-2 it is to be noted that substitution was the most common type of mutation, with LCL1 (627) having the most and LCL10 (301) having the least. Deletions and insertions were also observed ranging from 5 (Jijoye) to 11 (LCL-3) for deletion and 3 (Jijoye) to 10 (LCL-9) for insertion respectively.